SXB-203

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSXB-203
Drug Alias NameGb3 receptor antagonist (STxB Pharma Technologies)globotriaosylceramide receptor antagonist (STxB Pharma Technologies)SXB-203
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCD77 antagonists
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSTxB Pharma Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSTxB Pharma Technologies Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A